PMA device
VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)
Biosense Webster, Inc. · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Nov 6, 2024, newest Jun 30, 2026Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
17
Naming "VARIPULSE"
MAUDE reports
612
Brand "VARIPULSE", since 2015
PubMed studies
71
Mentioning "VARIPULSE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
P240006-S016 · Decided Jun 30, 2026 · 90 days after receipt · Normal 180 Day Track
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- VARIPULSE Platform (VARIPULSE Catheter; TRUPULSE Generator; Sterile Interface Cable; nGEN Pump)PMA supplement
P240006-S014 · Decided Feb 12, 2026 · 86 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- VARIPULSE (TM) Catheter; TRUPULSE (TM) Generator; Sterile Interface Cable; nGEN (TM) PumpPMA supplement
P240006-S001 · Decided May 9, 2025 · 154 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "VARIPULSE", any status and sponsor, newest update first.
- Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial FibrillationPivotal-lookingNot yet recruiting
China National Center for Cardiovascular DiseasesGovernment (non-federal)
NCT07926854 · 294 participants (planned) · Start Nov 2026 · Primary completion Dec 2028
Device: VARIPULSE Pulsed Field Ablation System · For: Atrial Fibrillation (AF)
Sites: Beijing, China
Biosense Webster, Inc.Public (JNJ)
NCT07227532 · 276 participants (planned) · Start Oct 21, 2025 · Primary completion Dec 31, 2030
Device: Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator · For: Atrial Fibrillation
Sites: Phoenix, Arizona; Tucson, Arizona; Fountain Valley, California · 25 sites in all
- A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAFActive, not recruiting
Biosense Webster, Inc.Public (JNJ)
NCT07429214 · 42 participants · Start Mar 23, 2026 · Primary completion Dec 30, 2026
Device: Pulsed Field Ablation System · For: Atrial Fibrillation
Sites: Aalst, Belgium; Bruges, Belgium; Aarhus N, Denmark · 6 sites in all
14 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VARIPULSE", and for the whole product code for context.
This brand
612 reports: 140 malfunction, 462 injury, 10 death
Whole product code QZI
10,522 reports: 5,457 malfunction, 4,777 injury, 245 death
Newest reports for this brand
- VARIPULSE¿ Bi-Directional CatheterMalfunction
3013300026-2026-03598 · Received Oct 29, 2026 · Event dated Sep 28, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Break; Communication or Transmission Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3013300026-2026-03603 · Received Oct 29, 2026 · Event dated Oct 1, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Asystole
- VARIPULSE¿ Bi-Directional CatheterMalfunction
3013300026-2026-03587 · Received Oct 28, 2026 · Event dated Sep 29, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1205-2025 · Started Jan 5, 2025 · Posted by FDA Feb 28, 2025
Reason given: Due to an observed trend of neurovascular events
Cause as FDA categorized it: Labeling design · Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Published research
The most relevant PubMed records for "VARIPULSE"[tiab]. The summary above synthesizes these.
- VARIPULSE: A step-by-step guide to pulmonary vein isolation.
Nair DG, Gomez T, De Potter T · J Cardiovasc Electrophysiol · 2024Review, Research Support, Non-U.S. Gov't
- Real-time detection of microembolic signals using carotid echocardiography: A comparative study of 3 pulsed-field systems.
Shiomi S, Tokuda M, Takato U, et al. · Heart Rhythm · 2026Comparative Study, Research Support, Non-U.S. Gov't
- Pulsed Field Ablation-Related Hemolysis: Comparison Between Technologies.
Gianni C, Al-Ahmad A, Elchouemi M, et al. · Circ Arrhythm Electrophysiol · 2025Comparative Study
- The VARIPULSE Pulsed Field Ablation Platform.
Amin R, Duytschaever M · Card Electrophysiol Clin · 2025Review
- Single-Center Real World Experience with the VARIPULSE Platform for Pulsed Field Ablation of Atrial Fibrillation, Atrial Flutter, and Redo Procedures.
Andria N, Abuiznait Z, Saad M, et al. · J Clin Med · 2025
- Pulsed-Field Ablation Circular Catheter Use in Left Superior Vena Cava-Associated Atrial Arrhythmias.
Li C, Yu X, Zhicheng H, et al. · JACC Case Rep · 2025Case Reports
- Thermal profiles of pulsed field ablation catheters.
Valappil SP, Kakarla SK, Puvrez A, et al. · Heart Rhythm · 2026
- Incidence and Characteristics of Superior Vena Cava Impact After Pulsed-Field Ablation of the Right Pulmonary Veins.
Matsuura H, Kamakura T, Oshima T, et al. · J Cardiovasc Electrophysiol · 2025Research Support, Non-U.S. Gov't
- Real-world adverse events of pulsed field ablation for atrial fibrillation: A comprehensive analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience database.
Hammadeh BM, Aldib L, Challa A, et al. · Heart Rhythm · 2026
- Real-World Safety of Two Pulsed Field Ablation Catheters for Atrial Fibrillation: A MAUDE Analysis.
Shoura SJ, Singireddy S, Coombes K, et al. · Pacing Clin Electrophysiol · 2026
- Effectiveness of AF pulsed field ablation with a variable-loop circular catheter: 12-month VARIPURE results.
Scherr D, Bessière F, Kronborg MB, et al. · Europace · 2026
- Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial.
Di Biase L, Reddy VY, Bahu M, et al. · Europace · 2025Multicenter Study, Comparative Study
Other devices of this type
Also filed under product code QZI.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation CatheterFarapulse, Inc. · PMA 2026
- Volt PFA SystemAbbott Medical · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- PulseSelect Pulsed Field Ablation (PFA) systemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- PulseSelect Pulse Field Ablation (PFA) CatheterMedtronic, Inc. · PMA 2026
- FARASTAR Pulsed Field Ablation (PFA) GeneratorFarapulse, Inc. · PMA 2025
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.